Paschalis Ntolios

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Hematopoietic Stem Cell

Ejection Fraction

Prognostic Factors

Top Venues

The clinical respiratory journal

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Athanasios Voulgaris, Kostas Archontogeorgis, Athanasia Pataka, Alexandros N Flaris, Paschalis Ntolios, Maria Rosaria Bonsignore, Sophia Schiza, Paschalis Steiropoulos
Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome. Medicina (Kaunas, Lithuania) 57 (11) (2021)
Paschalis Ntolios, Paschalis Steiropoulos, Georgia Karpathiou, Stavros Anevlavis, Theodoros Karampitsakos, Evangelos Bouros, Marios E Froudarakis, Demosthenes Bouros, Argyrios Tzouvelekis
Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 34 (5) (2021)
Paschalis Ntolios, Vassilios Tzilas, Evangelos Bouros, Eleni Avdoula, Ioannis Karakasiliotis, Demosthenes Bouros, Paschalis Steiropoulos
The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis. Biomedicines 9 (4) (2021)
Paschalis Ntolios, Eleni Manoloudi, Argyris Tzouvelekis, Evangelos Bouros, Pachalis Steiropoulos, Stavros Anevlavis, Demosthenes Bouros, Marios E Froudarakis
Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the adipose-derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. The clinical respiratory journal 12 (6) (2018)